The docosahexaenoic acid (DHA) market is witnessing significant growth driven by the increasing awareness of its health benefits, particularly for brain and heart health. DHA, a long-chain omega-3 fatty acid, is predominantly found in fish oils and algae, and is crucial for cognitive development, particularly in infants, as well as for maintaining cardiovascular health in adults. The demand for DHA is further fueled by the rising consumption of dietary supplements, fortified foods, and infant formulas enriched with DHA. Technological advancements in extraction and production methods, such as supercritical CO2 extraction and algae-based DHA sources, have expanded the supply and made it more sustainable. In addition, the growing preference for plant-based sources of omega-3 has boosted the use of algae-derived DHA, catering to vegan and vegetarian markets. Companies are also focusing on enhancing the bioavailability of DHA through innovative formulations and delivery systems. With increasing research supporting the positive impact of DHA on conditions such as Alzheimer's disease, depression, and pregnancy-related health issues, the market for DHA is expected to continue expanding, with key players advancing their production capabilities and introducing new products to meet the rising consumer demand.
